Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20935)

• Formulation Name: Terazosin 2 mg capsule
• Company: Mylan Pharamceuticals; PD-Rx Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terazosin	(DM3JCVS)	Benign prostatic hyperplasia	GA90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
D&C red no. 28	(E00491)	6097185	Colorant
D&C red no. 33	(E00261)	19116	Colorant
FD&C blue no. 1	(E00263)	19700	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent